Connect with us

International

WHO develops experimental Ebola vaccine

Published

on

WHO develops experimental Ebola vaccine

The World Health Organisations has revealed that it has developed an experimental vaccine for the dreaded Ebola virus which has been recorded in some African countries.

WHO says it hopes to deploy the experimental Ebola vaccine to tackle an outbreak in a remote area of the Congo Democratic Republic to prevent it spreading, particularly to the provincial capital which has over 1 million people.

Reports say WHO is moving quickly, having been criticised for bungling its response to a 2014-2016 outbreak that killed more than 11,300 people in Guinea, Sierra Leone and Liberia.

Read also: DRC: 17 feared dead as Ebola outbreak is confirmed

“We are very concerned and planning for all scenarios, including the worst case scenario,” Peter Salama, WHO’s Deputy Director-General of Emergency Preparedness and Response, told a regular U.N. briefing in Geneva.

Thus far, eleven new cases of haemorrhagic fever, including one death, have been reported since Tuesday in the DRC according to the Minister of Health Dr. Oly Ilunga.

Two of those cases recorded are confirmed to be Ebola and there are also pending results of nine other cases which are suspected to be Ebola.

 

RipplesNigeria… without borders, without fears

Click here to join the Ripples Nigeria WhatsApp group for latest updates.

Join the conversation

Opinions

Support Ripples Nigeria, hold up solutions journalism

Balanced, fearless journalism driven by data comes at huge financial costs.

As a media platform, we hold leadership accountable and will not trade the right to press freedom and free speech for a piece of cake.

If you like what we do, and are ready to uphold solutions journalism, kindly donate to the Ripples Nigeria cause.

Your support would help to ensure that citizens and institutions continue to have free access to credible and reliable information for societal development.

Donate Now